Again, nobiletin was demonstrated to induce antileukemic effects through the down-regulation of c-KIT gene in THP-1 cells [38], while treatment with diosmetin delayed tumor growth in AML mouse xenografts [39]. The gene discussed is KIT; the disease is neoplasm.